Apo-Risedronate 35 mg

APO-Risedronate 35 mg tablets are a medication used to treat osteoporosis and improve bone density. This oral tablet helps maintain bone health and reduce fracture risk.

APO-Risedronate 35 mg tablets are primarily used to treat osteoporosis in postmenopausal women. This medication works by slowing bone loss, helping to maintain bone density and reduce the risk of fractures. It is often prescribed for individuals with low bone mass or those at risk of osteoporosis-related bone breaks. The active ingredient, risedronate sodium, is a bisphosphonate that helps to strengthen bones and prevent further deterioration.

Common effects of APO-Risedronate 35 mg tablets may include mild stomach upset, heartburn, or diarrhea. Some users might experience muscle or joint pain. These effects are generally mild and temporary. If any severe or persistent symptoms occur, it is important to consult a healthcare provider.

APO-Risedronate 35 mg tablets should be taken with a full glass of water and while standing or sitting upright. It is important to avoid lying down for at least 30 minutes after taking the tablet to prevent irritation of the esophagus. Individuals with certain medical conditions, such as low calcium levels or severe kidney problems, should use this medication with caution. Always follow the advice of a healthcare professional regarding the use of this medication.

APO-Risedronate 35 mg tablets may interact with certain medications, including calcium supplements, antacids, and other oral medications. It is important to take this medication on an empty stomach, at least 30 minutes before eating or drinking anything other than water. Alcohol and certain foods may also affect the absorption of risedronate sodium, so it is advisable to avoid them around the time of taking this medication.